It has been postulated that an inflammatory response after cutaneous wounding is a prerequisite for healing, and inflammatory cytokines, such as interleukin-6 (IL-6), might be intimately involved in this process. IL-6-deficient transgenic mice (IL-6 KO) displayed significantly delayed cutaneous wound healing compared with wild-type control animals, requiring up to threefold longer to heal. This was characterized by minimal epithelial bridge formation, decreased inflammation, and granulation tissue formation. Using electrophoretic mobility shift assays of wound tissue from IL-6 KO mice, decreased AP-1 transcription factor activation was shown compared with wild-type mice 16 h after wounding. In situ hybridization of wound tissue from wild-type mice revealed IL-6 mRNA expression primarily in the epidermis at the leading edge of the wound. Delayed wound healing in IL-6 KO mice was reversed with a single dose of recombinant murine IL-6 or intradermal injection of an expression plasmid containing the full-length murine IL-6 cDNA. Treatment with rmIL-6 also reconstituted wound healing in dexamethasone-treated immunosuppressed mice. The results of this study may indicate a potential use for IL-6 therapeutically where cutaneous wound healing is impaired.

PACS 72.80. Jc, 78.66.Li, 81.10.Fq Transparent conductive Sn-doped β-Ga 2 O 3 single crystal with high crystallinity was successfully fabricated as a substrate for the growth of GaN-based compounds. Sn-doped β-Ga 2 O 3 single crystals were grown using a floating zone (FZ) method, and the properties of electrical conductivity, optical transmittance, and crystallinity were characterized to optimize the growth condition. It was found that these properties are controlled by the Sn doping concentration, and the specimen for 32 ppm Sn-doped β-Ga 2 O 3 single crystal was optimized to satisfy these properties simultaneously, i.e. the substrate with the internal optical transmittance of above ~85 % in the visible region, the electrical resistivity of 4.27×10 -2 Ωcm, the carrier density of 2.26×10 18 cm -3 , and the FWHM of X-ray rocking curve of 43 arcsec was obtained.

It has been postulated that the inflammatory response that occurs after cutaneous wounding is a prerequisite for healing and that inflammatory cytokines, such as interleukin-6 (IL-6) are involved in this process. We showed previously that IL-6-deficient mice display delayed wound healing, which could be reversed by administration of a murine IL-6 expression plasmid or recombinant murine IL-6 (rMuIL-6). In the present study, we observed that delayed cutaneous wound healing, which occurs as a result of glucocorticoid-induced immunosuppression, can also be reversed by rMuIL-6, as evidenced by epithelialization, granulation tissue formation, and wound closure. In vehicle control mice, rMuIL-6 did not augment healing but rather delayed the process. Immunochemical studies indicated that the expression of matrix metalloproteinase-10 (MMP-10) was increased in dexamethasone-treated mice and that rMuIL-6 treatment reduced its expression, indicating that IL-6 may influence dermal matrix formation and, specifically, collagen synthesis. These results demonstrate that IL-6 can restore abnormal wound repair that occurs in immunodeficiency and suggest its use as a potential therapy.

No abstract

No abstract

No abstract

No abstract

No abstract